Literature DB >> 18713026

Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Andrew G Gianoukakis1, Nicole Khadavi, Terry J Smith.   

Abstract

Graves' disease, an autoimmune process associated with thyroid dysfunction, can also manifest as remodeling of orbital connective tissue. Affected tissues exhibit immune responses that appear to be orchestrated by resident cells and those recruited from the bone marrow through their expression and release of cytokines and surface display of cytokine receptors. Cytokines are small molecules produced by many types of cells, including those of the "professional" immune system. Aberrant cytokine expression appears to play an important role in the pathogenesis of many human diseases, including thyroid autoimmunity. The skewed pattern of cytokine expression in the thyroid, including the T helper cell bias, may condition the response to apoptotic signals and determine the characteristics of an autoimmune reaction. Furthermore, chemoattractant cytokines, including IL16, RANTES, and CXCL10, elaborated by resident cells in the thyroid and orbit may provoke mononuclear cell infiltration. Other cytokines may drive cell activation and tissue remodeling. Thus cytokines and the signaling pathways they activate represent attractive therapeutic targets. Interruption of these might alter the natural course of Graves' disease and its orbital manifestations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713026      PMCID: PMC2879490          DOI: 10.1089/thy.2007.0405

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  69 in total

1.  Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.

Authors:  Nathalie Lévy Bohbot; Jacques Young; Jacques Orgiazzi; Catherine Buffet; Maud François; Brigitte Bernard-Chabert; Céline Lukas-Croisier; Brigitte Delemer
Journal:  Eur J Endocrinol       Date:  2006-03       Impact factor: 6.664

2.  Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease.

Authors:  Andrew G Gianoukakis; Raymond S Douglas; Chris S King; William W Cruikshank; Terry J Smith
Journal:  Endocrinology       Date:  2006-01-12       Impact factor: 4.736

3.  Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Authors:  Alessandro Antonelli; Mario Rotondi; Silvia Martina Ferrari; Poupak Fallahi; Paola Romagnani; Stefano Sellari Franceschini; Mario Serio; Ele Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

4.  Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression.

Authors:  Rui Han; Shanli Tsui; Terry J Smith
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

5.  T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Rui Han; Terry J Smith
Journal:  Endocrinology       Date:  2005-10-06       Impact factor: 4.736

Review 6.  Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases.

Authors:  N Mitsiades; V Poulaki; C S Mitsiades; D A Koutras; G P Chrousos
Journal:  Trends Endocrinol Metab       Date:  2001-11       Impact factor: 12.015

7.  CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.

Authors:  Ning Xia; Suxian Zhou; Yuzhen Liang; Changqing Xiao; Hanlei Shen; Hailin Pan; Hongming Deng; Naizun Wang; Qingdi Q Li
Journal:  Int J Mol Med       Date:  2006-05       Impact factor: 4.101

8.  Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts.

Authors:  Jane Pritchard; Noah Horst; William Cruikshank; Terry J Smith
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

9.  Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.

Authors:  M A García-López; D Sancho; F Sánchez-Madrid; M Marazuela
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

10.  Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins.

Authors:  G Stassi; D Di Liberto; M Todaro; A Zeuner; L Ricci-Vitiani; A Stoppacciaro; L Ruco; F Farina; G Zummo; R De Maria
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

View more
  33 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

2.  Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.

Authors:  Jin Zhang; Meng Ren; Hua Zeng; Ying Guo; Zhenwu Zhuang; Zhimei Feng; Haiyan Yan; Mingtong Xu; Weiwen Liang; Chuan Yang; Hua Cheng; Helin Ding; Li Yan
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

Review 3.  Immunopathogenesis of thyroid eye disease: emerging paradigms.

Authors:  Vibhavari M Naik; Milind N Naik; Robert A Goldberg; Terry J Smith; Raymond S Douglas
Journal:  Surv Ophthalmol       Date:  2010 May-Jun       Impact factor: 6.048

4.  Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Authors:  Danping Huang; Nuo Xu; Yiyue Song; Peijuan Wang; Huasheng Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-30       Impact factor: 3.117

Review 5.  Selected lid problems in neurologic practice.

Authors:  Gregory S Kosmorsky; Alyssa Fiddler
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

6.  Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy.

Authors:  Kai-Chun Cheng; Yu-Jen Wu; Kai-Hung Cheng; Kai-Yuan Cheng; Kuo-Jen Chen; Wen-Chuan Wu; Po-Yen Lee; Cheng-Hsien Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-03       Impact factor: 3.117

7.  Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.

Authors:  Hao Wang; Stephen J Atkins; Roshini Fernando; Rui-Li Wei; Terry J Smith
Journal:  Endocrinology       Date:  2015-08-19       Impact factor: 4.736

Review 8.  Thyroid dysfunction: an autoimmune aspect.

Authors:  Farah Aziz Khan; Noura Al-Jameil; Mohammad Fareed Khan; May Al-Rashid; Hajera Tabassum
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  F Procianoy; E Procianoy
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

10.  Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.

Authors:  Hong Chen; Tünde Mester; Nupur Raychaudhuri; Courtney Y Kauh; Shivani Gupta; Terry J Smith; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.